Examinando por Autor "Aroca, Gustavo"
Mostrando 1 - 3 de 3
Resultados por página
Opciones de clasificación
- PublicaciónAcceso abiertoMay Measurement Month 2017(ESC - European Society of Cardiology, 2019-04-01) Lopez-Jaramillo, Patricio; Otero, Johanna; Rueda-Quijano, Sandra Milena; Camacho López, Paul Anthony; Rey, Juan José; Sánchez, Gregorio; Narváez, Claudia; Accini, José Luis; Arcos, Edgar; García, Henry; Pérez, Maritza; Aroca, Gustavo; Beaney, Thomas; Kobeissi, Elsa; Poulter, Neil R.; MasiraDespite the availability of efficient methods to evaluate blood pressure (BP) and of safe and efficient medication to treat and control hypertension, the levels of awareness, treatment and control are very low globally, particularly in low- and middle-income countries. To highlight the importance of improving these rates, the International Society of Hypertension (ISH) endorsed by the World Hypertension League have implemented the May Measurement Month initiative. We present here the results obtained in Colombia. The Fundación Oftalmológica de Santander (FOSCAL) led the implementation of this strategy in Colombia and 11 departments participated. The data collection followed the guidelines of the ISH. The information collected was compiled for the report generation and the submission to the Technical Secretariat of the ISH. Data cleaning was performed locally by FOSCAL. Data were collated and analysed centrally. A total of 22 258 participants (58.8% female) were included in the analysis. Mean age was 40.9 ± 17.7 years. Age and sex-standardized BP excluding participants receiving BP medications was 118/74.3 mmHg, and in those on treatment 125/78 mmHg. High BP was present in 5036 (22.8%) individuals, 1637 of 18 644 (8.8%) who were not receiving anti-hypertensive medications were hypertensive, and 961 of 3359 (28.6%) receiving treatment were not controlled. These results highlight the need to develop innovative promotion strategies at individual and population levels to increase the awareness of the importance of BP, and the consequences of not having well-controlled hypertension. This initiative is an effective and easy to implement strategy that should be maintained in the coming years.
- PublicaciónAcceso abiertoMay Measurement Month 2018. An analysis of blood pressure screening results from Colombia(European Society of Cardiology, 2020-08-28) Lopez-Jaramillo, Patricio; Otero, Johanna; Alvernia, Juliana; Ney-Salazar, Daniela; Lopez-Lopez, Jose; Accini, Jose Luis; Aroca, Gustavo; Urina-Triana, Miguel; Sánchez-Vallejo, Gregorio; Arcos, Edgar; Casanova, María E.; García, Henry; Beaney, Thomas; Ster, Anca Chis; Poulter, Neil R.; MasiraHigh blood pressure (BP) is the leading global preventable cause of death and the most common risk factor for cardiovascular disease (CVD). However, due to its asymptomatic nature, the lack of awareness of this condition causes underdiagnosis and low rates of adherence to pharmacological treatment. Looking for practical approaches to increase awareness worldwide, the International Society of Hypertension (ISH) implemented the 2nd May Measurement Month campaign in 2018 (MMM18). In order to contribute to this initiative, Colombia participated as one of the 89 countries involved in this hypertension screening programme. Blood pressure was measured in subjects from 11 departments in Colombia. Under the leadership of the Fundación Oftalmológica de Santander (FOSCAL), 400 volunteers across the country collected the data following the MMM protocol. Measurements from 35 548 participants with a mean age of 41.9 years were obtained. In total, 9475 (26.7%) of the total population studied had hypertension. Of those with hypertension, 69.9% of these subjects were aware of their condition, 65.0% were on antihypertensive medication, and 43.1% had controlled BP. Of those on medication, 66.3% had controlled BP. Hypertension screening, awareness, treatment, and control should be a priority in public health objectives due to its elevated burden of disease and direct association with increased CVD. The MMM campaign provided a positive impact in the diagnosis of hypertension across Colombia. Although efforts are being made to expand treatment capability and adherence, still more are needed to insure a broader coverage of antihypertensive medication in Colombia.
- PublicaciónRestringidoRisk factors for preeclampsia in women from Colombia : A case-control study(2012-07-23) Reyes, Laura M.; García, Ronald G.; Ruiz, Silvia L.; Camacho López, Paul Anthony; Ospina, Maria B.; Aroca, Gustavo; Accini, Jose Luis; Lopez-Jaramillo, PatricioBackground: Preeclampsia (PE) is a multi-causal disease characterized by the development of hypertension and proteinuria in the second half of pregnancy. Multiple risk factors have been associated with the development of PE. Moreover, it is known that these risk factors vary between populations from developed and developing countries. The aim of this study is to identify which risk factors are associated with the development of preeclampsia (PE) among Colombian women. Methods: A multi-centre case-control study was conducted between September 2006 and July 2009 in six Colombian cities. Cases included women with PE (n = 201); controls were aged-matched pregnant women (n = 201) without cardiovascular or endocrine diseases for a case-control ratio of 1:1. A complete medical chart, physical examination and biochemical analysis were completed before delivery. Multivariable logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) of potential risk factors associated with PE. Results: The presence of factors present in the metabolic syndrome cluster such as body mass index .31 Kg/m2 (OR = 2.18; 1.14–4.14 95% CI), high-density lipoprotein ,1.24 mmol/L (OR = 2.42; 1.53–3.84 95% CI), triglycerides .3.24 mmol/L (OR = 1.60; 1.04–2.48 95% CI) and glycemia .4.9 mmol/L (OR = 2.66; 1.47–4.81 95%CI) as well as being primigravidae (OR = 1.71; 1.07–2.73 95% CI) were associated with the development of PE, after adjusting for other variables. Conclusion: Factors present in the cluster of metabolic syndrome and primigravidity were associated with a greater risk of PE among Colombian women. Understanding the role of this cluster of risk factors in the development of PE is of crucial importance to prevent PE and remains to be determined.